Glucose Biosensors Market Report 2022: Increasing Demand for Self-Monitoring Devices Drives 14.45% Annual Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Oct 5, 2022--

The "Glucose Biosensors Market Analysis, by Technology, by Product, by End Users and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The glucose biosensors market size is estimated to be USD 13,200 million in 2021 and is expected to witness a CAGR of 14.45% during the forecast period 2022-2029. The globally increasing self-monitoring device demand, modernizations in glucose biosensor technology, and a growing proportion of people worldwide developing diabetes are some of the primary market drivers. However, the strict regulatory framework and the high price of glucose biosensors are expected to restrain the market growth.

Regional Markets

In 2021, North America had the greatest share of the market due to the growing elderly population, diabetes's rising prevalence in the region, growing demand for remote and home monitoring, the increased incidence of diabetes brought on by lifestyle modifications, and improvements in technology.

However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the increasing public understanding of the benefits of early diagnosis to increase patient survival rates, growing incomes, the accessibility of sophisticated glucose biosensors from a variety of vendors, and enhancements to healthcare facilities and payment procedures.

Segmentation: Glucose Biosensors Market Analysis Report 2021-2029

Technology (Revenue, USD Million)

• Optical Biosensors
• Electrochemical Biosensors

Product (Revenue, USD Million)

• Self-Monitoring Blood Glucose (SMBG)
• Continuous Glucose Monitoring (CGM)

End User (Revenue, USD Million)

• Home Care
• Hospitals
• Diagnostic Centres & Clinics
• Others

By Region (Revenue, USD Million)

• U.S.
• Canada

• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

• Brazil
• Mexico
• Argentina
• Rest of LATAM

• South Africa
• GCC
• Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Glucose Biosensors

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Glucose Biosensors Market

7. Market Analysis by Technology

8. Market Analysis by Product

9. Market Analysis by End User

10. Regional Market Analysis

11. North America Glucose Biosensors Market

12. Europe Glucose Biosensors Market

13. Asia Pacific Glucose Biosensors Market

14. Latin America Glucose Biosensors Market

15. MEA Glucose Biosensors Market

16. Competitor Analysis

17. Company Profiles

18. Conclusion

19. Recommendations

Companies Mentioned

• Trividia Health (US)
• Sanofi (France)
• Nova Diabetes Care (USA)
• Lifescan (US)
• GlySens Incorporated (US)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Dexcom (US)
• Bayer (Germany)
• Ascenia Diabetes Care (Switzerland)
• Abbott Laboratories (US)

For more information about this report visit https://www.researchandmarkets.com/r/kl7etg

View source version on businesswire.com:https://www.businesswire.com/news/home/20221005005444/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: DIABETES HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2022.